ON-DEMAND POSTER
Patient-Derived Airway Organoids for Modelling Rhinovirus Infection
To access the poster, please fill out the form below. We'll send you a link to the materials shortly.
Our journey of pioneering organoid technology
2009
First organoid generated from mouse intestine
2011
First human organoid developed from intestinal epithelium
2013
Hubrecht Organoid Technology Foundation was established to upscale and commercialize organoid technology
2015
First cystic fibrosis patient treated based on organoid data
2017
HIT-CF validation trial launched
2018
First oncology clinical candidate entirely developed using organoid screening approved for clinical trials
2022
Expansion of lab facilities
2023
Hubrecht Organoid Technology becomes HUB Organoids B.V.
Explore our available resources
ORGANOID TECHNOLOGY
Single Lgr5 stem cell build crypt-villus structures in vitro without a mescenchymal niche
Nature | May 2009
ONCOLOGY
First clinical candidate developed using HUB Organoids in five years
Case study
ORGANOID TECHNOLOGY
The FDA Modernization Act 2.0: A patient-centric paradigm shift in drug development
Blog